Baosong Xie

484 citations
31 papers · 181 indexed · h-index 9
Topics
Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers)COVID-19 Clinical Research Studies (5 papers)SARS-CoV-2 and COVID-19 Research (4 papers)
Partner nations
ChinaBangladesh

In The Last Decade

Baosong Xie

26 papers receiving 178 citations

Peers

Baosong Xie
Comparison fields: 5 of 68
  • Infectious Diseases 54
  • Pulmonary and Respiratory Medicine 48
  • Epidemiology 46
  • Molecular Biology 38
  • Oncology 33
Replace Mélia Magnen with:
Mélia Magnen United States
Emi Yokoyama Japan
Funda Çipe Türkiye
Megan K. Fuller United States
Daniele Canarutto Italy
Miriam Conces United States
Lucas R. Massoth United States
Kaitlyn A. Barrow United States
Christopher R. D’Angelo United States
Xiaoyan He China
Baosong Xie relative to Mélia Magnen United States Mélia Magnen's profile →
Citations per field
00.5×1.5×2.3×
Mélia Magnen · 1×
Citations per year

Countries citing papers authored by Baosong Xie

Since Specialization
Citations

This map shows the geographic impact of Baosong Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baosong Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baosong Xie more than expected).

Fields of papers citing papers by Baosong Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baosong Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baosong Xie. The network helps show where Baosong Xie may publish in the future.

Co-authorship network of co-authors of Baosong Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Baosong Xie. A scholar is included among the top collaborators of Baosong Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baosong Xie. Baosong Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 1
5 0
6 2
7 2
8 4
9 11
10 2
11 0
12 0
13 13
14 2
15 9
16 2
17 1
18 17
19 25
20 2

About Baosong Xie

Baosong Xie is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Emergency Medical Services, having authored 31 papers that have together received 181 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), COVID-19 Clinical Research Studies (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Infectious Diseases (54 citations), Genetics (16 citations) and Pulmonary and Respiratory Medicine (48 citations). Baosong Xie has collaborated with scholars based in China and Bangladesh. Frequent co-authors include Yusheng Chen, Ming‐Tsan Lin, Hongru Li, Xiujuan Yao, Haitao Yang, Sheng Lin, Shuyun Xu, Yu-Sheng Chen, Jianjun Fu and Lili Han. Their work appears in journals such as Scientific Reports, Experimental Biology and Medicine and Cytokine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026